BMI vs. CORT

Last updated Jun 9, 2026

BMI (Badger Meter, Inc.) and CORT (Corcept Therapeutics Incorporated) are both stocks. BMI operates in Electrical Equipment & Parts (Industrials), while CORT operates in Biotechnology (Healthcare). Over the past 10 years, BMI returned 14.38%/yr vs 29.33%/yr for CORT. At a 0.22 correlation, their price movements are largely independent.

Performance

BMI vs. CORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Badger Meter, Inc. (BMI) and Corcept Therapeutics Incorporated (CORT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BMI achieves a -24.83% return, which is significantly lower than CORT's 110.72% return. Over the past 10 years, BMI has underperformed CORT with an annualized return of 14.38%, while CORT has yielded a comparatively higher 29.33% annualized return.

BMI

• 1D: 3.01%
• 1M: 10.34%
• YTD: -24.83%
• 6M: -26.08%
• 1Y: -46.65%
• 3Y*: -4.36%
• 5Y*: 7.73%
• 10Y*: 14.38%

CORT

• 1D: 0.98%
• 1M: 40.26%
• YTD: 110.72%
• 6M: -11.63%
• 1Y: 5.36%
• 3Y*: 46.50%
• 5Y*: 27.35%
• 10Y*: 29.33%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BMI vs. CORT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BMI Badger Meter, Inc.	-24.83%	-17.15%	38.28%	42.58%	3.23%	14.11%	46.37%	33.46%	4.09%	30.91%
CORT Corcept Therapeutics Incorporated	110.72%	-30.94%	55.14%	59.92%	2.58%	-24.31%	116.20%	-9.43%	-26.02%	148.76%

Correlation

The correlation between BMI and CORT is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (10Y) Calculated over the trailing 10-year period	0.27
Correlation (All Time) Calculated using the full available price history since Apr 14, 2004	0.22

Fundamentals

Market Cap BMI : $3.83B CORT : $7.66B
EPS BMI : $4.42 CORT : $0.41
PE Ratio BMI : 29.46 CORT : 178.81
PEG Ratio BMI : 1.23 CORT : 89.07
PS Ratio BMI : 4.29 CORT : 11.07
PB Ratio BMI : 3.94 CORT : 12.00
Total Revenue (TTM) BMI : $896.73M CORT : $769.10M
Gross Profit (TTM) BMI : $370.96M CORT : $755.64M
EBITDA (TTM) BMI : $199.34M CORT : $3.66M

Return for Risk

BMI vs. CORT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMI

BMI Risk / Return Rank: 6
BMI Sharpe Ratio Rank: 4
BMI Sortino Ratio Rank: 7
BMI Omega Ratio Rank: 4
BMI Calmar Ratio Rank: 8
BMI Martin Ratio Rank: 7

CORT

CORT Risk / Return Rank: 47
CORT Sharpe Ratio Rank: 44
CORT Sortino Ratio Rank: 47
CORT Omega Ratio Rank: 56
CORT Calmar Ratio Rank: 44
CORT Martin Ratio Rank: 44

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMI vs. CORT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Badger Meter, Inc. (BMI) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BMI	CORT	Difference
Sharpe ratio: Return per unit of total volatility	-1.06	0.07	-1.13
Sortino ratio: Return per unit of downside risk	-1.37	0.66	-2.03
Omega ratio: Gain probability vs. loss probability	0.78	1.14	-0.36
Calmar ratio: Return relative to maximum drawdown	-0.87	0.08	-0.95
Martin ratio: Return relative to average drawdown	-1.43	0.15	-1.58
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BMI vs. CORT - Sharpe Ratio Comparison

The current BMI Sharpe Ratio is -1.06, which is lower than the CORT Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of BMI and CORT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BMI	CORT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.06	0.07	-1.13
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.23	0.37	-0.14
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.43	0.44	-0.01
Sharpe Ratio (All Time) Calculated using the full available price history	0.44	0.11	+0.33

Drawdowns

BMI vs. CORT - Drawdown Comparison

The maximum BMI drawdown since its inception was -68.22%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for BMI and CORT.

Drawdown Indicators

	BMI	CORT	Difference
Max Drawdown Largest peak-to-trough decline	-68.22%	-94.28%	+26.06%
Max Drawdown (1Y) Largest decline over 1 year	-53.91%	-64.40%	+10.49%
Max Drawdown (3Y) Largest decline over 3 years	-55.06%	-71.85%	+16.79%
Max Drawdown (5Y) Largest decline over 5 years	-55.06%	-71.85%	+16.79%
Max Drawdown (10Y) Largest decline over 10 years	-55.06%	-71.85%	+16.79%
Current Drawdown Current decline from peak	-48.18%	-35.80%	-12.38%
Average Drawdown Average peak-to-trough decline	-19.02%	-53.44%	+34.42%
Ulcer Index Depth and duration of drawdowns from previous peaks	32.67%	35.34%	-2.67%

Volatility

BMI vs. CORT - Volatility Comparison

The current volatility for Badger Meter, Inc. (BMI) is 10.39%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 16.41%. This indicates that BMI experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BMI	CORT	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.39%	16.41%	-6.02%
Volatility (6M) Calculated over the trailing 6-month period	38.66%	85.07%	-46.41%
Volatility (1Y) Calculated over the trailing 1-year period	44.19%	76.73%	-32.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.88%	74.52%	-40.64%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.70%	67.22%	-33.52%

Dividends

BMI vs. CORT - Dividend Comparison

BMI's dividend yield for the trailing twelve months is around 1.23%, while CORT has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BMI Badger Meter, Inc.	1.23%	0.85%	0.58%	0.64%	0.78%	0.71%	0.74%	0.99%	1.14%	1.03%	1.16%	1.33%
CORT Corcept Therapeutics Incorporated	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

BMI vs. CORT - Profitability Comparison

The chart below illustrates the profitability comparison between Badger Meter, Inc. and Corcept Therapeutics Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BMI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Badger Meter, Inc. reported a gross profit of 84.33M and revenue of 202.28M. Therefore, the gross margin over that period was 41.7%.

CORT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.

BMI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Badger Meter, Inc. reported an operating income of 35.17M and revenue of 202.28M, resulting in an operating margin of 17.4%.

CORT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.

BMI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Badger Meter, Inc. reported a net income of 27.34M and revenue of 202.28M, resulting in a net margin of 13.5%.

CORT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.

Frequently Asked Questions

Can I hold both BMI and CORT in my portfolio?

BMI and CORT have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BMI or CORT?

CORT has higher volatility (16.41%) compared to BMI (10.39%). In terms of maximum drawdown, BMI dropped -68.22% vs CORT's -94.28%.

Which has better risk-adjusted returns?

CORT currently has the higher Sharpe Ratio (0.07 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.